Philip T Ho, MD
Otolaryngology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 7 carriers
- Offices
- 2
Offices
2 locations
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
28 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ho’s office at (408) 379-8228 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G88334 · Current
Licensed to practise in California · since 2008 · expires 2028-02-29 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$93,187
Medicare paid this office $93,187 for 215 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 140 | $24,717 | $120 |
| Removal of impacted ear wax | 142 | $9,433 | $44 |
| New patient visit (45+ min) | 52 | $7,908 | $152 |
| Short return visit (20+ min) | 67 | $7,435 | $85 |
| New patient visit (60+ min) | 25 | $5,204 | $208 |
See all 7 services
| Return visit (30+ min) | 140 | $24,717 | $120 |
| Removal of impacted ear wax | 142 | $9,433 | $44 |
| New patient visit (45+ min) | 52 | $7,908 | $152 |
| Short return visit (20+ min) | 67 | $7,435 | $85 |
| New patient visit (60+ min) | 25 | $5,204 | $208 |
| Diagnostic exam of voice box using a flexible endoscope | 17 | $3,061 | $133 |
| Diagnostic exam of nasal passages using an endoscope | 12 | $2,948 | $197 |
Procedures Medicare counted
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
215 Original Medicare patients in 2024. Average age 78 · Under 65 0% · 85 and older 24% · Women 51% · Health risk score 1.07. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 71% · Coronary heart disease 30% · Diabetes 22% · Atrial fibrillation 22% · Cancer 19% · Chronic kidney disease 17% · Depression 12% · Stroke 12% · Heart failure 11% · COPD 9% · Dementia 8%.
The office billed $265,660, Medicare allowed $118,476 and paid $93,187; for 722 services of 41 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 215 | 722 | 78 | 1.07 | $265,660 | $93,187 |
| 2023 | 222 | 745 | 78 | 1.04 | $268,223 | $92,330 |
| 2022 | 239 | 822 | 78 | 1.01 | $275,377 | $99,020 |
| 2021 | 242 | 932 | 78 | 1.06 | $273,342 | $107,188 |
| 2020 | 247 | 852 | 78 | 1.10 | $244,308 | $88,689 |
| 2019 | 279 | 1,033 | 77 | 1.24 | $327,181 | $118,026 |
| 2018 | 240 | 752 | 79 | 1.23 | $182,127 | $69,853 |
| 2017 | 243 | 821 | 79 | 1.21 | $193,730 | $74,238 |
| 2016 | 301 | 1,030 | 79 | 1.19 | $239,296 | $89,062 |
| 2015 | 280 | 983 | 78 | 1.20 | $125,315 | $83,608 |
| 2014 | 328 | 1,291 | 79 | 1.11 | $166,922 | $118,633 |
| 2013 | 106 | 340 | 76 | 1.11 | $81,945 | $49,994 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 134 | $24,687 | $120 |
| Removal of impacted ear wax | 144 | $9,854 | $45 |
| New patient visit (60+ min) | 41 | $8,224 | $201 |
| Short return visit (20+ min) | 52 | $6,009 | $85 |
| New patient visit (45+ min) | 39 | $5,964 | $153 |
| Diagnostic exam of nasal passages using an endoscope | 19 | $4,343 | $197 |
| Long return visit (40+ min) | 19 | $3,921 | $170 |
| Diagnostic exam of voice box using a flexible endoscope | 15 | $2,356 | $131 |
2022: 8 services
| Return visit (30+ min) | 155 | $29,395 | $118 |
| Removal of impacted ear wax | 149 | $9,672 | $43 |
| Long return visit (40+ min) | 42 | $9,542 | $170 |
| New patient visit (60+ min) | 41 | $8,296 | $202 |
| Short return visit (20+ min) | 59 | $6,143 | $81 |
| New patient visit (45+ min) | 37 | $5,685 | $154 |
| Diagnostic exam of voice box using a flexible endoscope | 28 | $4,864 | $135 |
| Diagnostic exam of nasal passages using an endoscope | 16 | $4,796 | $200 |
2021: 8 services
| Return visit (30+ min) | 163 | $31,341 | $114 |
| New patient visit (60+ min) | 65 | $13,304 | $205 |
| Removal of impacted ear wax | 164 | $12,073 | $42 |
| Long return visit (40+ min) | 52 | $11,707 | $170 |
| Short return visit (20+ min) | 57 | $6,245 | $81 |
| Diagnostic exam of voice box using a flexible endoscope | 26 | $5,007 | $135 |
| Diagnostic exam of nasal passages using an endoscope | 21 | $4,853 | $211 |
| New patient visit (45+ min) | 24 | $3,517 | $147 |
2020: 8 services
| Return visit (30+ min) | 167 | $26,110 | $96 |
| New patient visit (60+ min) | 54 | $10,051 | $186 |
| Removal of impacted ear wax | 147 | $9,694 | $42 |
| Short return visit (20+ min) | 67 | $5,970 | $69 |
| Diagnostic exam of voice box using a flexible endoscope | 31 | $5,441 | $127 |
| New patient visit (45+ min) | 36 | $5,402 | $150 |
| Diagnostic exam of nasal passages using an endoscope | 19 | $4,497 | $196 |
| Long return visit (40+ min) | 18 | $2,225 | $111 |
2019: 10 services
| Return visit (30+ min) | 171 | $27,158 | $96 |
| New patient visit (60+ min) | 85 | $15,329 | $180 |
| Diagnostic exam of nasal passages using an endoscope | 35 | $10,080 | $206 |
| Removal of impacted ear wax | 154 | $8,483 | $40 |
| Diagnostic exam of voice box using a flexible endoscope | 50 | $7,310 | $114 |
| Long return visit (40+ min) | 45 | $7,035 | $130 |
| Short return visit (20+ min) | 75 | $6,693 | $64 |
| New patient visit (45+ min) | 33 | $4,656 | $141 |
| Reshaping of nasal cartilage | 11 | $4,624 | $420 |
| Removal of nasal air passage under lining tissue | 11 | $1,308 | $119 |
2018: 8 services
| Return visit (30+ min) | 114 | $18,974 | $97 |
| New patient visit (60+ min) | 47 | $8,639 | $184 |
| Short return visit (20+ min) | 95 | $8,613 | $61 |
| Removal of impacted ear wax | 137 | $7,791 | $42 |
| Diagnostic exam of voice box using a flexible endoscope | 43 | $6,470 | $108 |
| New patient visit (45+ min) | 34 | $5,043 | $148 |
| Diagnostic exam of nasal passages using an endoscope | 13 | $3,225 | $215 |
| Long return visit (40+ min) | 18 | $2,866 | $136 |
2017: 7 services
| Return visit (30+ min) | 102 | $16,178 | $99 |
| Short return visit (20+ min) | 122 | $12,003 | $64 |
| Removal of impacted ear wax | 150 | $10,208 | $42 |
| Diagnostic exam of voice box using a flexible endoscope | 41 | $6,513 | $112 |
| New patient visit (45+ min) | 47 | $6,172 | $131 |
| New patient visit (60+ min) | 33 | $6,075 | $184 |
| Long return visit (40+ min) | 11 | $1,760 | $135 |
2016: 9 services
| Short return visit (20+ min) | 164 | $17,782 | $64 |
| Return visit (30+ min) | 106 | $16,631 | $97 |
| Removal of impacted ear wax | 184 | $13,064 | $43 |
| New patient visit (45+ min) | 75 | $10,445 | $139 |
| Diagnostic exam of voice box using a flexible endoscope | 41 | $6,155 | $108 |
| New patient visit (60+ min) | 32 | $5,755 | $180 |
| Diagnostic exam of nasal passages using an endoscope | 15 | $3,308 | $207 |
| New patient visit (30+ min) | 20 | $1,795 | $90 |
| Short return visit | 11 | $448 | $37 |
2015: 8 services
| Return visit (30+ min) | 92 | $14,325 | $96 |
| Removal of impacted ear wax | 189 | $12,981 | $43 |
| Short return visit (20+ min) | 133 | $12,514 | $63 |
| New patient visit (45+ min) | 85 | $12,308 | $145 |
| Diagnostic exam of voice box using a flexible endoscope | 52 | $8,681 | $110 |
| New patient visit (60+ min) | 18 | $3,412 | $190 |
| New patient visit (30+ min) | 15 | $1,515 | $101 |
| Short return visit | 28 | $1,300 | $38 |
2014: 8 services
| New patient visit (45+ min) | 168 | $24,262 | $144 |
| Removal of impacted ear wax | 214 | $17,187 | $45 |
| Return visit (30+ min) | 118 | $17,107 | $99 |
| Short return visit (20+ min) | 111 | $12,942 | $67 |
| Diagnostic exam of voice box using a flexible endoscope | 65 | $10,202 | $110 |
| New patient visit (30+ min) | 78 | $6,885 | $88 |
| New patient visit (60+ min) | 11 | $2,072 | $188 |
| Short return visit | 21 | $1,494 | $40 |
2013: 4 services
| New patient visit (45+ min) | 49 | $7,304 | $149 |
| Diagnostic exam of voice box using a flexible endoscope | 37 | $5,754 | $111 |
| Short return visit (20+ min) | 52 | $5,395 | $67 |
| Return visit (30+ min) | 34 | $4,292 | $100 |
Drugs they prescribed that Part D paid
$2,345
Pharmacies billed $2,345 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 139) in 2024. At or below the middle of the specialty; the typical otolaryngology clinician is at 4%.
136 generic and fewer than 11 brand-name prescriptions · $2,345 in drug cost · 54 antibiotic prescriptions to 33 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Methylprednisolone | 32 | $314 | $6 |
| Amoxicillin-Clavulanate Potass | 18 | $234 | $8 |
| Azithromycin | 11 | $76 | $4 |
Year by year
| 2024 | 139 | 62 | 0% (0) | None | $2,345 |
| 2023 | 155 | 69 | 0% (0) | None | $4,879 |
| 2022 | 221 | 76 | 0% (0) | None | $5,657 |
| 2021 | 187 | 71 | None | None | $6,320 |
| 2020 | 179 | 81 | None | 6% | $5,841 |
| 2019 | 217 | 77 | None | None | $5,120 |
| 2018 | 197 | 81 | None | None | $4,804 |
| 2017 | 266 | 102 | None | None | $7,565 |
| 2016 | 265 | 82 | None | None | $8,623 |
| 2015 | 248 | 96 | None | 6% | $7,366 |
| 2014 | 261 | 108 | None | 5% | $8,609 |
| 2013 | 128 | 51 | None | 9% | $4,778 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Methylprednisolone | 50 | $516 | $10 |
| Amoxicillin-Clavulanate Potass | 36 | $516 | $14 |
2022: 3 drugs
| Amoxicillin-Clavulanate Potass | 56 | $1,165 | $21 |
| Methylprednisolone | 90 | $877 | $10 |
| Azithromycin | 17 | $78 | $5 |
2021: 3 drugs
| Amoxicillin-Clavulanate Potass | 47 | $622 | $13 |
| Methylprednisolone | 58 | $535 | $9 |
| Fluticasone Propionate | 15 | $220 | $15 |
2020: 6 drugs
| Neomycin-Polymyxin-Hc | 15 | $1,723 | $115 |
| Amoxicillin-Clavulanate Potass | 31 | $531 | $17 |
| Methylprednisolone | 45 | $461 | $10 |
| Fluticasone Propionate | 15 | $296 | $20 |
| Amoxicillin | 13 | $95 | $7 |
| Omeprazole | 11 | $68 | $6 |
2019: 6 drugs
| Neomycin-Polymyxin-Hc | 17 | $1,778 | $105 |
| Amoxicillin-Clavulanate Potass | 45 | $751 | $17 |
| Methylprednisolone | 56 | $694 | $12 |
| Fluticasone Propionate | 26 | $449 | $17 |
| Azithromycin | 13 | $117 | $9 |
| Omeprazole | 13 | $104 | $8 |
2018: 5 drugs
| Neomycin-Polymyxin-Hc | 22 | $2,075 | $94 |
| Methylprednisolone | 52 | $625 | $12 |
| Fluticasone Propionate | 31 | $356 | $11 |
| Amoxicillin-Clavulanate Potass | 22 | $313 | $14 |
| Omeprazole | 14 | $136 | $10 |
2017: 6 drugs
| Neomycin-Polymyxin-Hc | 23 | $1,993 | $87 |
| Methylprednisolone | 71 | $892 | $13 |
| Fluticasone Propionate | 55 | $839 | $15 |
| Amoxicillin-Clavulanate Potass | 25 | $402 | $16 |
| Mupirocin | 26 | $370 | $14 |
| Omeprazole | 24 | $187 | $8 |
2016: 6 drugs
| Neomycin-Polymyxin-Hc | 38 | $3,239 | $85 |
| Clotrimazole | 11 | $989 | $90 |
| Methylprednisolone | 54 | $834 | $15 |
| Fluticasone Propionate | 63 | $738 | $12 |
| Amoxicillin-Clavulanate Potass | 26 | $470 | $18 |
| Chlorhexidine Gluconate | 14 | $64 | $5 |
2015: 5 drugs
| Ciprodex | 12 | $3,322 | $277 |
| Fluticasone Propionate | 93 | $1,063 | $11 |
| Neomycin-Polymyxin-Hc | 20 | $941 | $47 |
| Methylprednisolone | 32 | $567 | $18 |
| Omeprazole | 40 | $493 | $12 |
2014: 5 drugs
| Neomycin-Polymyxin-Hc | 60 | $1,945 | $32 |
| Fluticasone Propionate | 56 | $1,224 | $22 |
| Methylprednisolone | 35 | $737 | $21 |
| Omeprazole | 33 | $365 | $11 |
| Amox Tr-Potassium Clavulanate | 15 | $282 | $19 |
2013: 4 drugs
| Neomycin-Polymyxin-Hc | 25 | $1,023 | $41 |
| Fluticasone Propionate | 25 | $903 | $36 |
| Omeprazole | 19 | $383 | $20 |
| Methylprednisolone | 13 | $302 | $23 |
Money from drug and device companies
$710 in 2025
| 2025 | 7 | 16 | None | $710 |
| 2024 | 3 | 6 | None | $298 |
| 2023 | 4 | 10 | None | $439 |
| 2022 | 4 | 7 | None | $150 |
| 2021 | 3 | 7 | None | $267 |
| 2020 | 4 | 4 | None | $222 |
| 2019 | 5 | 7 | None | $282 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $332 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $143 | 4 payments
|
| Aerin Medical | Vivaer Stylus | $97 | 2 payments
|
| Inspire Medical Systems | Inspire | $70 | 2 payments
|
| Medtronic | Propel | $23 | 1 payment
|
| Smith+Nephew | Tula | $23 | 1 payment
|
See all 16 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-19 | Tezspire | $30 |
| GlaxoSmithKline | Meals · 2025-11-12 | Nucala | $33 |
| GlaxoSmithKline | Meals · 2025-09-18 | Nucala | $123 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-18 | None | $60 |
| Smith+Nephew | Meals · 2025-09-18 | Tula | $23 |
| Inspire Medical Systems | Meals · 2025-09-16 | Inspire | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-09 | Tezspire | $21 |
| GlaxoSmithKline | Meals · 2025-08-26 | Nucala | $24 |
| Aerin Medical | Meals · 2025-08-20 | Vivaer Stylus | $45 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-26 | None | $32 |
| Aerin Medical | Meals · 2025-07-22 | Vivaer Stylus | $52 |
| Inspire Medical Systems | Meals · 2025-07-09 | Inspire | $39 |
| GlaxoSmithKline | Meals · 2025-06-25 | Nucala | $27 |
| GlaxoSmithKline | Meals · 2025-06-25 | Nucala | $125 |
| Medtronic | Meals · 2025-02-03 | Propel | $23 |
| Grifols USA | Meals · 2025-01-21 | Gamunex-C | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $298
| Optinose US | Xhance | $137 | 1 payment
|
| Inspire Medical Systems | Inspire | $136 | 4 payments
|
| Coherus Biosciences | Loqtorzi | $25 | 1 payment
|
2023: $439
| Inspire Medical Systems | Inspire | $341 | 7 payments
|
| Aerin Medical | Vivaer Stylus | $43 | 1 payment
|
| Medtronic | Ligasure | $29 | 1 payment
|
| Optinose US | Xhance | $25 | 1 payment
|
2022: $150
| Aerin Medical | None | $79 | 3 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $35 | 2 payments
|
| Genzyme | Dupixent | $19 | 1 payment
|
| Stryker | Xpress Ent Dilation System | $16 | 1 payment
|
2021: $267
| Aerin Medical | Vivaer Stylus | $177 | 3 payments
|
| Stryker | Xpress Ent Dilation System | $48 | 2 payments
|
| OptiNose US | Xhance | $43 | 2 payments
|
2020: $222
| Genzyme | Dupixent | $125 | 1 payment
|
| Aerin Medical | Vivaer | $40 | 1 payment
|
| Intersect ENT | Sinuva | $37 | 1 payment
|
| OptiNose US | Xhance | $20 | 1 payment
|
2019: $282
| OptiNose US | Xhance | $180 | 3 payments
|
| Genzyme | Dupixent | $38 | 1 payment
|
| Cook Medical | Cook Medical Sleep | $26 | 1 payment
|
| Smith+Nephew | Coblation - Turbinate Wands | $21 | 1 payment
|
| Stryker | Entellus - Xpress Ent Dilation System | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1760579718
- Licence
- CA G88334, CT 040296, NY 200165California G88334: Current · expires 2028-02-29
- Trained
- Georgetown University School of Medicine, 1993
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CT 00-140-2966
- Taxonomy
- Otolaryngology (207Y00000X); Federal specialty code 207YS0012X (207YS0012X); Federal specialty code 207YX0905X (207YX0905X)
- Mailing address
- 700 W Parr Ave, Suite B, Los Gatos, CA, 95032
- NPI first listed
- 2006-10-09
- NPI last updated
- 2011-11-19
This is when the NPI record was last certified, not a medical board exam.